tiprankstipranks
Rosetta Genomics Ltd (ROSGQ)
OTHER OTC:ROSGQ
US Market

Rosetta Genomics (ROSGQ) Income Statement

Compare
63 Followers

Rosetta Genomics Income Statement

Last quarter (Q0 0), Rosetta Genomics's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Rosetta Genomics's net income was $-2.07M. See Rosetta Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 16Dec 15Dec 14Dec 13Dec 12
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 1.79M$ 2.00M$ 17.00K$ -304.00K$ -57.00K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -15.32M$ -16.53M$ -13.95M$ -12.85M$ -10.10M
Operating Income
$ -15.66M$ -15.88M$ -14.25M$ -13.35M$ -8.27M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -16.23M$ -17.34M$ -14.53M$ -12.90M$ -10.46M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Rosetta Genomics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis